Global Noninfectious Chronic Disease (NCDs) Health Management Software Market Research Report 2024

Chronic diseases, also known as Noninfectious Chronic Diseases (NCDs), are long-term, non-healing, and hardly curable diseases. It mainly refers to those diseases with morbidity, disability, high mortality, high medical costs, and clear prevention measures. The software helps to record, calculate and manage personal physiological index with a shared cloud platform or database.

The global Noninfectious Chronic Disease (NCDs) Health Management Software market was valued at US$ 1509 million in 2023 and is anticipated to reach US$ 2432.8 million by 2030, witnessing a CAGR of 7.1% during the forecast period 2024-2030.

Noninfectious chronic diseases, such as diabetes, cardiovascular disease, and obesity, continue to be a significant global health concern. The increasing prevalence of NCDs has driven the demand for software solutions that support disease management and prevention. The COVID-19 pandemic accelerated the adoption of telehealth and remote patient monitoring solutions. NCD health management software has become an integral part of these telehealth platforms, enabling remote monitoring of patients with chronic conditions. Artificial intelligence (AI) and machine learning are being used to analyze patient data and predict disease progression or complications. These technologies enhance the accuracy of treatment recommendations and care planning. Ensuring that NCD health management software can integrate with electronic health record (EHR) systems and other healthcare IT solutions is crucial for seamless care coordination and data exchange.

This report aims to provide a comprehensive presentation of the global market for Noninfectious Chronic Disease (NCDs) Health Management Software, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Noninfectious Chronic Disease (NCDs) Health Management Software.

Report Scope

The Noninfectious Chronic Disease (NCDs) Health Management Software market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Noninfectious Chronic Disease (NCDs) Health Management Software market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Noninfectious Chronic Disease (NCDs) Health Management Software companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation


By Company


GE Healthcare

Virtualhealth

Livongo Health, Inc.

Honeywell

IDCP MedTech

Vital Connect

Symplr

Conduent

Xyhis

Jinan Good Medical Technology Co.,Ltd.

Philips Healthcare

Medtronic

Cerner Corporation

Epic Systems Corporation

McKesson Corporation

Athenahealth

Allscripts

IBM Watson Health

WellDoc

Omada Health

Livongo


Segment by Type


Health Alerts

Physiological Index Recording

Consultation Service


Segment by Application


Hospital

Family

Nursing Home

By Region

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Noninfectious Chronic Disease (NCDs) Health Management Software companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of the report.

Frequently Asked Questions